Literature DB >> 19222824

Impact of intense, longitudinal retreatment with praziquantel on cure rates of schistosomiasis mansoni in a cohort of occupationally exposed adults in western Kenya.

Carla L Black1, Michelle L Steinauer, Pauline N M Mwinzi, W Evan Secor, Diana M S Karanja, Daniel G Colley.   

Abstract

OBJECTIVE: To investigate trends in the efficacy of praziquantel (PZQ) suggestive of the emergence of drug resistance against Schistosoma mansoni infection after 12.5 years of intense, repeated use in a small geographic area along the shores of Lake Victoria.
METHODS: As part of a longitudinal study, 178 men occupationally exposed to schistosomes were repeatedly tested for S. mansoni infection at 4- to 6-week intervals and treated with PZQ at each reinfection. We compared cure rates by year of study and examined factors associated with cure failure in a multivariate logistic regression model.
RESULTS: Overall, the cure rate after a single dose of PZQ was 66%, ranging annually from 36% to 82%. In multivariate analysis, failure to cure after 1 PZQ dose was significantly associated with high intensity of infection and having fewer previous exposures to dying worms. Even after adjustment for these factors, treatments administered in 2006 were significantly more likely to result in cure failures than treatments administered in 2004, the year in which PZQ efficacy was highest. While cure rates varied over the course of 12 years, there was no consistent downward trend towards decreased efficacy over time. In years for which malacological data were available, periods of low PZQ efficacy coincide with high rates of S. mansoni infection in nearby snail populations.
CONCLUSION: We did not find a pattern of cure failures consistent with development of clinical resistance to PZQ in our intensely treated cohort.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19222824      PMCID: PMC2941893          DOI: 10.1111/j.1365-3156.2009.02234.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  26 in total

1.  Increased exposure of parasite antigens at the surface of adult male Schistosoma mansoni exposed to praziquantel in vitro.

Authors:  W Harnett; J R Kusel
Journal:  Parasitology       Date:  1986-10       Impact factor: 3.234

2.  The chemotherapeutic effect of praziquantel against Schistosoma mansoni is dependent on host antibody response.

Authors:  P J Brindley; A Sher
Journal:  J Immunol       Date:  1987-07-01       Impact factor: 5.422

3.  Immune dependence of schistosomicidal chemotherapy: an ultrastructural study of Schistosoma mansoni adult worms exposed to praziquantel and immune serum in vivo.

Authors:  J Modha; J R Lambertucci; M J Doenhoff; D J McLaren
Journal:  Parasite Immunol       Date:  1990-05       Impact factor: 2.280

4.  Chemotherapy-based control of schistosomiasis haematobia. 3. Snail studies monitoring the effect of chemotherapy on transmission in the Msambweni area, Kenya.

Authors:  R F Sturrock; H Kinyanjui; F W Thíongo; S Tosha; J H Ouma; C H King; D Koech; T K Siongok; A A Mahmoud
Journal:  Trans R Soc Trop Med Hyg       Date:  1990 Mar-Apr       Impact factor: 2.184

5.  A statistical approach to schistosome population dynamics and estimation of the life-span of Schistosoma mansoni in man.

Authors:  A J Fulford; A E Butterworth; J H Ouma; R F Sturrock
Journal:  Parasitology       Date:  1995-04       Impact factor: 3.234

6.  Efficacy of praziquantel against Schistosoma japonicum: field evaluation in an area with repeated chemotherapy compared with a newly identified endemic focus in Hunan, China.

Authors:  D B Yu; Y Li; A C Sleigh; X L Yu; Y S Li; W Y Wei; Y S Liang; D P McManus
Journal:  Trans R Soc Trop Med Hyg       Date:  2001 Sep-Oct       Impact factor: 2.184

7.  Studies on schistosomiasis in western Kenya: II. Efficacy of praziquantel for treatment of schistosomiasis in persons coinfected with human immunodeficiency virus-1.

Authors:  D M Karanja; A E Boyer; M Strand; D G Colley; B L Nahlen; J H Ouma; W E Secor
Journal:  Am J Trop Med Hyg       Date:  1998-08       Impact factor: 2.345

8.  Distribution patterns and cercarial shedding of Bulinus nasutus and other snails in the Msambweni area, Coast Province, Kenya.

Authors:  H Curtis Kariuki; Julie A Clennon; Melinda S Brady; Uriel Kitron; Robert F Sturrock; John H Ouma; Saidi Tosha Malick Ndzovu; Peter Mungai; Orit Hoffman; Joseph Hamburger; Cara Pellegrini; Eric M Muchiri; Charles H King
Journal:  Am J Trop Med Hyg       Date:  2004-04       Impact factor: 2.345

9.  Efficacy and side effects of praziquantel against Schistosoma mansoni in a community of western Côte d'Ivoire.

Authors:  Giovanna Raso; Eliézer K N'Goran; Abale Toty; Anne Luginbühl; Cynthia A Adjoua; Norbert T Tian-Bi; Isaac I Bogoch; Penelope Vounatsou; Marcel Tanner; Jürg Utzinger
Journal:  Trans R Soc Trop Med Hyg       Date:  2004-01       Impact factor: 2.184

10.  The global status of schistosomiasis and its control.

Authors:  L Chitsulo; D Engels; A Montresor; L Savioli
Journal:  Acta Trop       Date:  2000-10-23       Impact factor: 3.112

View more
  32 in total

Review 1.  Applying evolutionary genetics to schistosome epidemiology.

Authors:  Michelle L Steinauer; Michael S Blouin; Charles D Criscione
Journal:  Infect Genet Evol       Date:  2010-02-20       Impact factor: 3.342

2.  Assessment of quality of life as a tool for measuring morbidity due to Schistosoma mansoni infection and the impact of treatment.

Authors:  Kimberly Y Won; Bernard Abudho; Anna J Blackstock; Susan P Montgomery; Erin D Kennedy; Bobbie Person; Pauline N M Mwinzi; Elizabeth A Ochola; Karen T Foo; Allen W Hightower; Diana M S Karanja; W Evan Secor
Journal:  Am J Trop Med Hyg       Date:  2013-12-09       Impact factor: 2.345

Review 3.  Circulating antigen tests and urine reagent strips for diagnosis of active schistosomiasis in endemic areas.

Authors:  Eleanor A Ochodo; Gowri Gopalakrishna; Bea Spek; Johannes B Reitsma; Lisette van Lieshout; Katja Polman; Poppy Lamberton; Patrick M M Bossuyt; Mariska M G Leeflang
Journal:  Cochrane Database Syst Rev       Date:  2015-03-11

4.  Effectiveness of synthetic trioxolane OZ78 against Schistosoma japonicum in mice and rabbits.

Authors:  Shu-Hua Xiao; Jian Xue; Jing-Yan Mei; Pei-Ying Jiao
Journal:  Parasitol Res       Date:  2011-12-27       Impact factor: 2.289

5.  Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni.

Authors:  Maha M Eissa; Mervat Z El-Azzouni; Labiba K El-Khordagui; Amany Abdel Bary; Riham M El-Moslemany; Sara A Abdel Salam
Journal:  Parasit Vectors       Date:  2020-09-15       Impact factor: 3.876

6.  Influence of exposure history on the immunology and development of resistance to human Schistosomiasis mansoni.

Authors:  Carla L Black; Pauline N M Mwinzi; Erick M O Muok; Bernard Abudho; Colin M Fitzsimmons; David W Dunne; Diana M S Karanja; W Evan Secor; Daniel G Colley
Journal:  PLoS Negl Trop Dis       Date:  2010-03-23

Review 7.  Advances in the Diagnosis of Human Schistosomiasis.

Authors:  Kosala G A D Weerakoon; Geoffrey N Gobert; Pengfei Cai; Donald P McManus
Journal:  Clin Microbiol Rev       Date:  2015-10       Impact factor: 26.132

8.  Effect of single-dose oral mefloquine on the morphology of adult Schistosoma japonicum in mice.

Authors:  Shu-Hua Xiao; Jacques Chollet; Jürg Utzinger; Jin-Yan Mei; Pei-Yin Jiao; Jennifer Keiser; Marcel Tanner
Journal:  Parasitol Res       Date:  2009-05-21       Impact factor: 2.289

9.  Efficacy and safety of arachidonic acid for treatment of Schistosoma mansoni-infected children in Menoufiya, Egypt.

Authors:  Sahar Selim; Ola El Sagheer; Azza El Amir; Rashida Barakat; Kevin Hadley; Maaike J Bruins; Rashika El Ridi
Journal:  Am J Trop Med Hyg       Date:  2014-09-22       Impact factor: 2.345

10.  Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni.

Authors:  Sandra D Melman; Michelle L Steinauer; Charles Cunningham; Laura S Kubatko; Ibrahim N Mwangi; Nirvana Barker Wynn; Martin W Mutuku; Diana M S Karanja; Daniel G Colley; Carla L Black; William Evan Secor; Gerald M Mkoji; Eric S Loker
Journal:  PLoS Negl Trop Dis       Date:  2009-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.